EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

GH-dependent growth of experimentally induced carcinomas in vivo

Paul C Marker, Christopher J Unterberger, Steven M Swanson iD

Endocrine-Related Cancer · 2023

DOI: 10.1530/erc-22-0403 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrine-Related Cancer, 2023. Verfasst von Paul C Marker und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Pharmaceutical Sciences Division, University of Wisconsin-Madison, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Human Growth Hormone, Carcinoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interest in investigating the role of the growth hormone (GH)/insulin-like growth factor 1 (IGF-1) axis in the initiation and progression of experimentally induced carcinomas has arisen due to several observations in the human population. First, subjects with Laron syndrome who lack GH signaling have significantly lower rates of cancer than people who have normal GH signaling. Second, epidemiologic studies have found strong associations between elevated circulating IGF-1 and the incidence of several common cancers. Third, women who bear children early in life have a dramatically reduced risk of developing breast cancer, which may be due to differences in hormone levels including GH. These observations have motivated multiple studies that have experimentally altered activity of the GH/IGF-1 axis in the context of experimental carcinoma models in mice and rats. Most of these studies have utilized carcinoma models for four organ systems that are also frequent sites of carcinomas in humans: the mammary gland, prostate gland, liver, and colon. This review focuses on these studies and describes some of the most common genetic models used to alter the activity of the GH/IGF-1 axis in experimentally induced carcinomas. A recurring theme that emerges from these studies is that manipulations that reduce the activity of GH or mediators of GH action also inhibit carcinogenesis in multiple model systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Human Growth HormoneCarcinomaMaleFemaleRatsMiceHumansAnimalsGrowth HormoneInsulin-Like Growth Factor INeoplasm Recurrence, Local

Stichwörter der Autor:innen

IGF-1carcinomacolongrowth hormone (GH)livermammary glandprostate gland

Substanzen

Growth HormoneInsulin-Like Growth Factor IHuman Growth Hormone

Autor:innen und Institutionen

  • School of Pharmacy, Pharmaceutical Sciences Division, University of Wisconsin-Madison, Madison, Wisconsin, USA.

ORCID-Profile: Steven M Swanson

Förderung

  • NCI NIH HHS

Zitieren

APA

Marker, P. C., Unterberger, C. J., & Swanson, S. M. (2023). GH-dependent growth of experimentally induced carcinomas in vivo. Endocrine-Related Cancer. https://doi.org/10.1530/erc-22-0403

Vancouver

Marker PC, Unterberger CJ, Swanson SM. GH-dependent growth of experimentally induced carcinomas in vivo. Endocrine-Related Cancer. 2023. doi:10.1530/erc-22-0403

BibTeX
@article{Marker2023,
  author = {Marker, Paul C and Unterberger, Christopher J and Swanson, Steven M},
  title = {GH-dependent growth of experimentally induced carcinomas in vivo},
  journal = {Endocrine-Related Cancer},
  year = {2023},
  doi = {10.1530/erc-22-0403}
}
Kostenlos starten →